Breast CancerDiagnostics and screening
What this study is
This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to participants.
What's being tested
- No Interventions
Intervention · OTHER
No intervention for participants.
Study details
- Official title
- UCF MammoChat: An AI-Driven Platform for Personalized Breast Cancer Patient Support -Image Repository
- Sponsor
- University of Central Florida
- Conditions
- Breast Cancer · Breast Cancer Awareness · Breast Cancer Detection · Breast Cancer Survivors · Breast Cancer Female · Breast Cancer Diagnosis
- Enrolling
- 20,000 people
- Starts
- 2025-09-03
- Est. completion
- 2026-06-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Adults, ages 18 and older
- Had a radiographic breast cancer imaging test, either for screening or diagnosis of breast cancer, with either positive or negative results performed in a US institution.
- Have an email account with access to a reliable internet connection or smartphone
- Pregnant women may choose to participate.
You can't join if
- Minors , ages under 18
- Prisoners
- Adults who are unable to provide consent.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of Central Florida
Orlando, Florida, United States
- Amoy Fraser, PhD, CCRP, PMP · Contact4072668742britney-ann.wray@ucf.edu
- Britney-Ann Wray, BS, CCRP, CTBS · Contact4072668742britney-ann.wray@ucf.edu
- Jane C Gibson, PhD · Principal investigator
Recruiting
Study team
Sponsor
University of Central Florida
Study ID STUDY00008263
Principal investigator
Jane Gibson, PhD
University of Central Florida
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.